G. Krishna
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 2%
Papers in
-
- Phosphodiesterase function and regulation 7
- Receptor Mechanisms and Signaling 4
- Retinal Development and Disorders 4
- Physiology 16
- Adipose Tissue and Metabolism 8
- Nitric Oxide and Endothelin Effects 5
- Adenosine and Purinergic Signaling 4
- Co-authors
- Erik Frandsen (2 shared papers)B.B. Brodie (7 shared papers)S. Hynie (4 shared papers)C.L. Kapoor (3 shared papers)N. Krishnan (3 shared papers)Watson D. Reid (3 shared papers)Lance R. Pohl (1 shared paper)Gerald J. Chader (5 shared papers)
- Journals
- Life Sciences (6 papers)Biochimica et Biophysica Acta (BBA) - General Subjects (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Biochemical and Biophysical Research Communications (3 papers)Pharmacology (2 papers)
- Partner nations
- United StatesMalaysiaIndia
In The Last Decade
G. Krishna
65 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 123
- Pharmacology 394
- Biochemistry 212
- Cellular and Molecular Neuroscience 448
- Physiology 101
- Physiology 422
Countries citing papers authored by G. Krishna
This map shows the geographic impact of G. Krishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Krishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Krishna more than expected).
Fields of papers citing papers by G. Krishna
This network shows the impact of papers produced by G. Krishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Krishna. The network helps show where G. Krishna may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Krishna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 306 | |
| 2 | Interrelationships of catecholamines with other endocrine systems. | 1966 | 123 |
| 3 | 1976 | 119 | |
| 4 | 1971 | 115 | |
| 5 | 1994 | 102 | |
| 6 | 1976 | 101 | |
| 7 | 1980 | 98 | |
| 8 | 1968 | 82 | |
| 9 | 1966 | 78 | |
| 10 | 1978 | 62 | |
| 11 | 2001 | 61 | |
| 12 | 1973 | 60 | |
| 13 | 1978 | 59 | |
| 14 | 1975 | 59 | |
| 15 | 1977 | 59 | |
| 16 | 1976 | 58 | |
| 17 | 1980 | 56 | |
| 18 | 1981 | 56 | |
| 19 | 1970 | 47 | |
| 20 | 1970 | 42 |
About G. Krishna
G. Krishna is a scholar working on Molecular Biology, Physiology, Pharmacology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 65 papers that have together received 2.4k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (8 papers), Phosphodiesterase function and regulation (7 papers), Nitric Oxide and Endothelin Effects (5 papers), Receptor Mechanisms and Signaling (4 papers), Retinal Development and Disorders (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Adenosine and Purinergic Signaling (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Pharmacology (394 citations), Biochemistry (212 citations), Cellular and Molecular Neuroscience (448 citations), Physiology (101 citations) and Physiology (422 citations). G. Krishna has collaborated with scholars based in United States, Malaysia and India. Frequent co-authors include Erik Frandsen, B.B. Brodie, S. Hynie, C.L. Kapoor, N. Krishnan, Watson D. Reid, Lance R. Pohl, Gerald J. Chader, I.F. Skidmore and J. ISLWYN DAVIES. Their work appears in journals such as Life Sciences, Biochimica et Biophysica Acta (BBA) - General Subjects, Journal of Pharmacology and Experimental Therapeutics, Biochemical and Biophysical Research Communications and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.